Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis

Background: The association between antiphospholipid antibodies (aPL) and multiple sclerosis (MS) has been suggested previously, but prior studies provided contradicting findings. Objectives: To characterize the expression profile of eight classic and non-classic aPL in patients diagnosed with MS. M...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2015
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22196
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/22196
Palabra clave:
Beta2 glycoprotein 1
Cardiolipin antibody
Immunoglobulin g
Immunoglobulin m
Phosphatidylethanolamine
Phosphatidylserine
Phospholipid antibody
Prothrombin
Prothrombin complex
Immunoglobulin g
Immunoglobulin m
Phospholipid antibody
Adult
Antibody titer
Article
Controlled study
Disease duration
Female
Flow cytometry
Fluorescence analysis
Human
Immunoassay
Major clinical study
Male
Middle aged
Multiple sclerosis
Protein expression
Blood
Case control study
Cross-sectional study
Immunology
Multiple sclerosis
Prevalence
Adult
Case-control studies
Cross-sectional studies
Female
Humans
Immunoglobulin g
Immunoglobulin m
Male
Middle aged
Multiple sclerosis
Prevalence
Antiphospholipid syndrome (aps)
Autoantibodies
Autoimmunity
Beta 2-glycoprotein 1 (?2gpi)
Cardiolipin
Immunoglobulin (ig)
Multiple sclerosis (ms)
antiphospholipid
Antibodies
Rights
License
Abierto (Texto Completo)
id EDOCUR2_f72432165b3093fc50ba0a3eb46d6db3
oai_identifier_str oai:repository.urosario.edu.co:10336/22196
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling b127ed71-9c39-45a6-9c93-29553e3f42d3f8dbc4d4-eab5-4bf6-8e08-8f3c977ffd086d20c285-9d8e-4321-9514-05d9dd6d04ed31adaa6e-685e-4fb3-a0eb-946c45c8b329194747786006b286b69-16c0-4eae-a12c-57f7a4b4c7599b47b011-2a68-42a2-b9f5-81df561062432020-05-25T23:55:44Z2020-05-25T23:55:44Z2015Background: The association between antiphospholipid antibodies (aPL) and multiple sclerosis (MS) has been suggested previously, but prior studies provided contradicting findings. Objectives: To characterize the expression profile of eight classic and non-classic aPL in patients diagnosed with MS. Methods: Using the BioPlex™ 2200 immunoassay, we measured the levels of serum immunoglobulin (Ig)M and IgG isotypes of three classic aPL and five non-classic aPL in 98 subjects with MS and 237 healthy controls. Results: Three non-classic aPL were significantly more prevalent among MS patients in comparison to the control group. These antibodies included IgM and IgG against phosphatidylserine- ?2GPI (PS-B2), IgG prothrombin complex (PT-PT) and IgM prothrombin (PT). The positive results according to Bonferroni correction are PS-B2 IgG and PT-PT IgG. The remaining aPL profiles did not differ significantly between the two groups. Conclusions: An association between certain non-classic aPL and MS has been established. The specific role of these autoantibodies in the pathogenesis of the condition remains uncertain. © 2015, Israel Medical Association. All rights reserved.application/pdf15651088https://repository.urosario.edu.co/handle/10336/22196engIsrael Medical Association562No. 9559Israel Medical Association JournalVol. 17Israel Medical Association Journal, ISSN:15651088, Vol.17, No.9 (2015); pp. 559-562https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943655947&partnerID=40&md5=447de3270c9e2afafa340f94a019e1faAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURBeta2 glycoprotein 1Cardiolipin antibodyImmunoglobulin gImmunoglobulin mPhosphatidylethanolaminePhosphatidylserinePhospholipid antibodyProthrombinProthrombin complexImmunoglobulin gImmunoglobulin mPhospholipid antibodyAdultAntibody titerArticleControlled studyDisease durationFemaleFlow cytometryFluorescence analysisHumanImmunoassayMajor clinical studyMaleMiddle agedMultiple sclerosisProtein expressionBloodCase control studyCross-sectional studyImmunologyMultiple sclerosisPrevalenceAdultCase-control studiesCross-sectional studiesFemaleHumansImmunoglobulin gImmunoglobulin mMaleMiddle agedMultiple sclerosisPrevalenceAntiphospholipid syndrome (aps)AutoantibodiesAutoimmunityBeta 2-glycoprotein 1 (?2gpi)CardiolipinImmunoglobulin (ig)Multiple sclerosis (ms)antiphospholipidAntibodiesPrevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosisarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Shor D.B.-A.Weiss G.A.Barzilai O.Ram M.Anaya, Juan-ManuelShoenfeld Y.Sherer Y.10336/22196oai:repository.urosario.edu.co:10336/221962022-05-02 07:37:13.265393https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
title Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
spellingShingle Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
Beta2 glycoprotein 1
Cardiolipin antibody
Immunoglobulin g
Immunoglobulin m
Phosphatidylethanolamine
Phosphatidylserine
Phospholipid antibody
Prothrombin
Prothrombin complex
Immunoglobulin g
Immunoglobulin m
Phospholipid antibody
Adult
Antibody titer
Article
Controlled study
Disease duration
Female
Flow cytometry
Fluorescence analysis
Human
Immunoassay
Major clinical study
Male
Middle aged
Multiple sclerosis
Protein expression
Blood
Case control study
Cross-sectional study
Immunology
Multiple sclerosis
Prevalence
Adult
Case-control studies
Cross-sectional studies
Female
Humans
Immunoglobulin g
Immunoglobulin m
Male
Middle aged
Multiple sclerosis
Prevalence
Antiphospholipid syndrome (aps)
Autoantibodies
Autoimmunity
Beta 2-glycoprotein 1 (?2gpi)
Cardiolipin
Immunoglobulin (ig)
Multiple sclerosis (ms)
antiphospholipid
Antibodies
title_short Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
title_full Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
title_fullStr Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
title_full_unstemmed Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
title_sort Prevalence of classic and non-classic antiphospholipid antibodies in multiple sclerosis
dc.subject.keyword.spa.fl_str_mv Beta2 glycoprotein 1
Cardiolipin antibody
Immunoglobulin g
Immunoglobulin m
Phosphatidylethanolamine
Phosphatidylserine
Phospholipid antibody
Prothrombin
Prothrombin complex
Immunoglobulin g
Immunoglobulin m
Phospholipid antibody
Adult
Antibody titer
Article
Controlled study
Disease duration
Female
Flow cytometry
Fluorescence analysis
Human
Immunoassay
Major clinical study
Male
Middle aged
Multiple sclerosis
Protein expression
Blood
Case control study
Cross-sectional study
Immunology
Multiple sclerosis
Prevalence
Adult
Case-control studies
Cross-sectional studies
Female
Humans
Immunoglobulin g
Immunoglobulin m
Male
Middle aged
Multiple sclerosis
Prevalence
Antiphospholipid syndrome (aps)
Autoantibodies
Autoimmunity
Beta 2-glycoprotein 1 (?2gpi)
Cardiolipin
Immunoglobulin (ig)
Multiple sclerosis (ms)
topic Beta2 glycoprotein 1
Cardiolipin antibody
Immunoglobulin g
Immunoglobulin m
Phosphatidylethanolamine
Phosphatidylserine
Phospholipid antibody
Prothrombin
Prothrombin complex
Immunoglobulin g
Immunoglobulin m
Phospholipid antibody
Adult
Antibody titer
Article
Controlled study
Disease duration
Female
Flow cytometry
Fluorescence analysis
Human
Immunoassay
Major clinical study
Male
Middle aged
Multiple sclerosis
Protein expression
Blood
Case control study
Cross-sectional study
Immunology
Multiple sclerosis
Prevalence
Adult
Case-control studies
Cross-sectional studies
Female
Humans
Immunoglobulin g
Immunoglobulin m
Male
Middle aged
Multiple sclerosis
Prevalence
Antiphospholipid syndrome (aps)
Autoantibodies
Autoimmunity
Beta 2-glycoprotein 1 (?2gpi)
Cardiolipin
Immunoglobulin (ig)
Multiple sclerosis (ms)
antiphospholipid
Antibodies
dc.subject.keyword.eng.fl_str_mv antiphospholipid
Antibodies
description Background: The association between antiphospholipid antibodies (aPL) and multiple sclerosis (MS) has been suggested previously, but prior studies provided contradicting findings. Objectives: To characterize the expression profile of eight classic and non-classic aPL in patients diagnosed with MS. Methods: Using the BioPlex™ 2200 immunoassay, we measured the levels of serum immunoglobulin (Ig)M and IgG isotypes of three classic aPL and five non-classic aPL in 98 subjects with MS and 237 healthy controls. Results: Three non-classic aPL were significantly more prevalent among MS patients in comparison to the control group. These antibodies included IgM and IgG against phosphatidylserine- ?2GPI (PS-B2), IgG prothrombin complex (PT-PT) and IgM prothrombin (PT). The positive results according to Bonferroni correction are PS-B2 IgG and PT-PT IgG. The remaining aPL profiles did not differ significantly between the two groups. Conclusions: An association between certain non-classic aPL and MS has been established. The specific role of these autoantibodies in the pathogenesis of the condition remains uncertain. © 2015, Israel Medical Association. All rights reserved.
publishDate 2015
dc.date.created.spa.fl_str_mv 2015
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:55:44Z
dc.date.available.none.fl_str_mv 2020-05-25T23:55:44Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.issn.none.fl_str_mv 15651088
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22196
identifier_str_mv 15651088
url https://repository.urosario.edu.co/handle/10336/22196
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 562
dc.relation.citationIssue.none.fl_str_mv No. 9
dc.relation.citationStartPage.none.fl_str_mv 559
dc.relation.citationTitle.none.fl_str_mv Israel Medical Association Journal
dc.relation.citationVolume.none.fl_str_mv Vol. 17
dc.relation.ispartof.spa.fl_str_mv Israel Medical Association Journal, ISSN:15651088, Vol.17, No.9 (2015); pp. 559-562
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943655947&partnerID=40&md5=447de3270c9e2afafa340f94a019e1fa
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Israel Medical Association
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167633608572928